GlassScriptPhysician profile
Keith E Davis
NPI 1952344947
$7,374.76
in general payments reported to CMS, 2019-2025
35 companies · $741 in 2025
The $741 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,278 · 2020: $476 · 2021: $771 · 2022: $1,668 · 2023: $1,874 · 2024: $566 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,181.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,697.48 | 2019-2025 | Watchman Access System, Rotablator Rotational Atherectomy System Console Kit, Opticross |
| Preventric Diagnostics, INC. | $934.82 | 2022 | |
| Abiomed | $667.64 | 2019-2022 | |
| Teleflex LLC | $508.66 | 2022-2025 | Turnpike, Trapliner, Vascband |
| Cardiovascular Systems INC. | $387.35 | 2019-2022 | |
| Abbott Laboratories | $359.42 | 2019-2025 | Cardiomems, Amplatzer Amulet, Perclose Proglide |
| Inari Medical, INC. | $279.20 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $273.21 | 2021-2023 | Telescope, Linq II |
| Asahi Intecc USA, INC. | $239.53 | 2021-2023 | Asahi Ptca Guide Wire |
| Shockwave Medical, INC | $192.43 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $180.60 | 2020-2023 | Wainua |
| Cleerly, INC. | $175.00 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.74 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $168.51 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $150.69 | 2023-2024 | Xarelto |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opsens INC. | $117.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $115.99 | 2019 | |
| Alnylam Pharmaceuticals INC. | $113.48 | 2019 | |
| Pfizer INC. | $108.13 | 2019-2025 | |
| Philips North America LLC | $84.13 | 2019-2025 | Coronary Other |
| Amgen INC. | $81.21 | 2019-2025 | Repatha |
| Cardiva Medical, INC. | $61.51 | 2019-2025 | Savvywire, Optowire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.37 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $46.23 | 2020-2025 | |
| Chiesi USA, INC. | $41.96 | 2019-2022 | |
| Angiodynamics, INC. | $24.16 | 2025 | Alphavac |
| Cardinal Health 200 LLC | $22.42 | 2019 | |
| Atricure, INC. | $19.81 | 2022 | |
| Celgene Corporation | $16.64 | 2024 | Camzyos |
| Novo Nordisk INC | $16.05 | 2021 | |
| Bridgebio Pharma, INC. | $15.18 | 2025 | Attruby |
| Amarin Pharma, INC. | $14.47 | 2021 | |
| Biotronik INC. | $14.34 | 2019 | |
| Braemar Manufacturing, LLC | $13.74 | 2019 | |
| Merck Sharp & Dohme LLC | $13.33 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.